Antibiotic Use in Geriatric Patients

Introduction to Antibiotic Considerations

• The American Geriatrics Society recommends using trimethoprim-sulfamethoxazole (TMP-SMX) with caution in patients with reduced kidney function who are taking ACE inhibitors or ARBs due to increased risk of hyperkalemia 1, 2

Dose Adjustments for Antibiotics

• The American Journal of Kidney Diseases suggests that fluoroquinolones require significant dose adjustment in renal impairment, with ciprofloxacin dose reduced by 50% when GFR < 15 ml/min/1.73 m² 3
• The American Journal of Kidney Diseases recommends reducing the dose of macrolides by 50% when GFR < 30 ml/min/1.73 m² 3
• The American Journal of Kidney Diseases advises that penicillins have a risk of crystalluria when GFR < 15 ml/min/1.73 m² with high doses, and neurotoxicity with benzylpenicillin when GFR < 15 ml/min/1.73 m² with high doses (maximum 6 g/day) 3

Drug-Drug Interactions

• The American Geriatrics Society warns that TMP-SMX with phenytoin or warfarin increases the risk of phenytoin toxicity and bleeding 2
• The American Geriatrics Society cautions that macrolides (excluding azithromycin) or ciprofloxacin with warfarin increases bleeding risk 2
• The American Geriatrics Society notes that ciprofloxacin with theophylline increases the risk of theophylline toxicity 2

Safer Alternatives for Geriatric Patients

• The European Urology association suggests that for UTIs in elderly patients, fosfomycin, nitrofurantoin, and pivmecillinam may be preferred options when appropriate for the infection 4, 5
• The European Urology association recommends considering the local resistance patterns when selecting empiric therapy, and being aware that not recognizing atypical presentation of infections in elderly patients can lead to delayed diagnosis and treatment 4, 5

Safe Use of Antibiotics in Elderly Patients with Renal Impairment

Introduction to Renal Considerations

• The European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy recommends avoiding drugs that are cleared via the kidneys or known nephrotoxic agents in elderly patients with impaired renal function 6

Dosing and Renal Function

• If levofloxacin must be used, significant dosage adjustment is required based on creatinine clearance, with dosing as follows: For CrCl 20-49 ml/min: 750 mg initially, then 750 mg every 48 hours, For CrCl 10-19 ml/min: 500 mg initially, then 500 mg every 48 hours, For severe renal impairment (CrCl <10 ml/min): 500 mg initially, then 500 mg every 48 hours 7
• Always calculate creatinine clearance to determine appropriate dosing for renally eliminated medications in geriatric patients 7

Alternative Antibiotic Selection

• Within each antibiotic class, preference should be given to agents less likely to be influenced by renal clearance 8
• Within each antibiotic class, preference should be given to agents less likely to be toxic to the kidneys 8

Avoiding Common Pitfalls

• Relying solely on serum creatinine without calculating creatinine clearance can lead to inappropriate dosing in elderly patients 9

Renal Dosing and Safety Considerations for Levofloxacin in Elderly Patients

Renal Dose Adjustments (CDC MMWR Recommendations)

These dosing regimens are recommended by the CDC’s MMWR Recommendations and Reports 10.

• Levofloxacin is eliminated primarily by the kidneys (≈ 80% renal excretion) → dose reduction is required when CrCl < 50 mL/min. [CDC, MMWR] 10.

Adverse‑Event Frequencies (CDC MMWR Recommendations)

• Gastro‑intestinal adverse effects occur in 0.5–1.8 % of patients, neurologic effects in 0.5 %, and cutaneous reactions in 0.2–0.4 %. [CDC, MMWR] 10.

• Co‑administration of levofloxacin with antacids or other medications containing divalent cations (e.g., calcium, magnesium, iron) within 2 hours markedly reduces fluoroquinolone absorption; such combinations should be avoided. [CDC, MMWR] 10.

Ciprofloxacin Renal Dosing Guidance (American Geriatrics Society)

• Expert consensus from geriatric clinical pharmacists recommends specific dose reductions or interval extensions for ciprofloxacin in elderly patients with renal impairment. [American Geriatrics Society, JAGS] 11.

• The same consensus is reiterated in a separate 2009 JAGS publication, emphasizing the need for individualized dosing based on measured GFR. [American Geriatrics Society, JAGS] 12.